Idera proposes follow-on

Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass. Business: Cancer, Infectious, Autoimmune Date announced: 3/11/13 Type: Follow-on To be raised: Up to $40 million Shares: TBD Price prior: $0....